Mack Michael J, Pfister Albert, Bachand Donna, Emery Robert, Magee Mitchell J, Connolly Mark, Subramanian Valavanur
Cardiopulmonary Research Science and Technology Institute, Medical City Dallas Hospital, TX, USA.
J Thorac Cardiovasc Surg. 2004 Jan;127(1):167-73. doi: 10.1016/j.jtcvs.2003.08.032.
Coronary artery bypass grafting can now be performed with or without cardiopulmonary bypass. Our objective was to determine whether off-pump coronary artery bypass grafting is associated with better early outcomes compared with conventional coronary artery bypass grafting.
In 4 centers with off-pump coronary surgery experience, a retrospective analysis of all coronary artery bypass grafting in a 3-year period was performed. Groups were compared to determine selection criteria, mortality, and morbidity, then computer-matched by propensity score to control for selection bias. Multivariate logistic regression identified risk factors predictive of mortality. Specific subgroups most likely to benefit were identified.
In all, 17,401 isolated coronary artery bypass grafts were performed, 7283 (41.9%) off-pump coronary artery bypass grafts and 10,118 (58.1%) conventional coronary artery bypass with cardiopulmonary bypass. Factors determining selection of patients for off-pump coronary artery bypass grafting included female gender (55.5% vs 44.5%), preexisting renal failure (57.0% vs 43.0%), and reoperations (52.6% vs 47.4%). Operative mortality was 2.8%; off-pump coronary artery bypass grafting versus conventional coronary artery bypass with cardiopulmonary bypass (1.9% vs 3.5%, P <.001) had the same predicted risk. Of the patients with multivessel disease, 11,548 were matched by propensity scoring. Mortality was significantly less in the off-pump coronary artery bypass grafting group (2.8% vs 3.7%, P <.001). By multivariate logistic regression analysis of the matched sample, predictors for mortality were female gender (odds ratio 1.83, confidence interval 1.37-2.44), preexisting renal failure (odds ratio 2.85, confidence interval 2.64-4.95), history of stroke (odds ratio 1.74, confidence interval 1.08-2.80), previous coronary artery bypass grafting surgery (odds ratio 4.22, confidence interval 2.92-6.09), use of cardiopulmonary bypass (odds ratio 2.08, confidence interval 1.52-2.83), and recent myocardial infarction (odds ratio 2.31, confidence interval 1.68-3.22). Cardiopulmonary bypass was predictive of mortality in reoperations, female patients, and patients aged >or= 75 years. Off-pump coronary artery bypass grafting was associated with less morbidity, including reductions in blood transfusion (32.6% vs 40.6%, P <.001), stroke (1.4% vs 2.1%, P =.002), renal failure (2.6% vs 5.2%, P <.001), pulmonary complications (4.1% vs 9.5%, P <.001), reoperation (1.7% vs 3.2%, P <.001), atrial fibrillation (21.1% vs 24.99%, P <.001), and gastrointestinal complications (3.6% vs 4.8%, P =.02).
In 4 centers with beating-heart operation experience, there is an overall early benefit in off-pump surgery, especially in patients traditionally considered at high risk for coronary artery bypass grafting.
冠状动脉旁路移植术现在可以在有或没有体外循环的情况下进行。我们的目的是确定与传统冠状动脉旁路移植术相比,非体外循环冠状动脉旁路移植术是否具有更好的早期疗效。
在4个有非体外循环冠状动脉手术经验的中心,对3年内所有冠状动脉旁路移植术进行回顾性分析。比较各组以确定选择标准、死亡率和发病率,然后通过倾向评分进行计算机匹配以控制选择偏倚。多因素逻辑回归确定预测死亡率的危险因素。确定了最可能受益的特定亚组。
总共进行了17401例单纯冠状动脉旁路移植术,其中7283例(41.9%)为非体外循环冠状动脉旁路移植术,10118例(58.1%)为传统体外循环冠状动脉旁路移植术。决定选择非体外循环冠状动脉旁路移植术患者的因素包括女性(55.5%对44.5%)、既往肾衰竭(57.0%对43.0%)和再次手术(52.6%对47.4%)。手术死亡率为2.8%;非体外循环冠状动脉旁路移植术与传统体外循环冠状动脉旁路移植术(1.9%对3.5%,P<.001)具有相同的预测风险。在多支血管病变患者中,11548例通过倾向评分进行匹配。非体外循环冠状动脉旁路移植术组的死亡率显著较低(2.8%对3.7%,P<.001)。通过对匹配样本的多因素逻辑回归分析,死亡率的预测因素为女性(比值比1.83,置信区间1.37 - 2.44)、既往肾衰竭(比值比2.85,置信区间2.64 - 4.95)、中风史(比值比1.74,置信区间1.08 - 2.80)、既往冠状动脉旁路移植手术史(比值比4.22,置信区间2.92 - 6.09)、使用体外循环(比值比2.08,置信区间1.52 - 2.83)和近期心肌梗死(比值比2.31,置信区间1.68 - 3.22)。体外循环是再次手术、女性患者和年龄≥75岁患者死亡率的预测因素。非体外循环冠状动脉旁路移植术的发病率较低,包括输血减少(32.6%对40.6%,P<.001)、中风(1.4%对2.1%,P =.002)、肾衰竭(2.6%对5.2%,P<.001)、肺部并发症(4.1%对9.5%,P<.001)、再次手术(1.7%对3.2%,P<.001)、心房颤动(21.1%对24.99%,P<.001)和胃肠道并发症(3.6%对4.8%,P =.02)。
在4个有心脏不停跳手术经验的中心,非体外循环手术总体上有早期益处,尤其是在传统上被认为冠状动脉旁路移植术高风险的患者中。